<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To test at the population level whether people with multiple <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (<z:chebi fb="1" ids="25255">MMS</z:chebi>) disorders have reduced cardiac autonomic activity (CAA) </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: We examined the association between the level of CAA and <z:chebi fb="1" ids="25255">MMS</z:chebi> disorders, at the degree of clustering and the segregate combination levels, using a random sample of 2,359 men and women aged 45-64 years from the biracial, population-based <z:hpo ids='HP_0002621'>Atherosclerosis</z:hpo> Risk in Communities (ARIC) Study </plain></SENT>
<SENT sid="2" pm="."><plain>Supine resting 2-min beat-to-beat heart rate data were collected </plain></SENT>
<SENT sid="3" pm="."><plain>High-frequency (HF) (0.15-0.35 Hz) and low-frequency (LF) (0.025-0.15 Hz) spectral powers, the ratio of LF to HF, and the SD of <z:hpo ids='HP_0000001'>all</z:hpo> <z:mpath ids='MPATH_458'>normal</z:mpath> R-R intervals (SDNN) were used as the conventional indices of heart rate variability (HRV) to measure CAA </plain></SENT>
<SENT sid="4" pm="."><plain>The <z:chebi fb="1" ids="25255">MMS</z:chebi> disorders included <z:hpo ids='HP_0000822'>hypertension</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: HRV indices were significantly lower in individuals with <z:chebi fb="1" ids="25255">MMS</z:chebi> disorders </plain></SENT>
<SENT sid="6" pm="."><plain>The multivariable adjusted mean HF was 0.85 (beat/min)2 in subjects with <z:hpo ids='HP_0000001'>all</z:hpo> three <z:chebi fb="1" ids="25255">MMS</z:chebi> disorders, in contrast to 1.31 (beat/min)2 in subjects without any <z:chebi fb="1" ids="25255">MMS</z:chebi> disorder </plain></SENT>
<SENT sid="7" pm="."><plain>At the segregated combination level, the multivariable adjusted means +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e> of HF were 1.34 +/- 0.05, 1.16 +/- 0.05, 1.01 +/- 0.17, and 1.34 +/- 0.05 (beat/min)2, respectively, for subjects without any <z:chebi fb="1" ids="25255">MMS</z:chebi> disorder, with <z:hpo ids='HP_0000822'>hypertension</z:hpo> only, with <z:mp ids='MP_0002055'>diabetes</z:mp> only, and with <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> only, and the means +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e> of HF were 0.93 +/- 0.04, 0.70 +/- 0.15, and 1.20 +/- 0.05 (beat/min)2, respectively, for subjects with <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, and <z:hpo ids='HP_0000822'>hypertension</z:hpo> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>An increase in fasting insulin of 1 SD was associated with 88% higher odds of having a lower HF </plain></SENT>
<SENT sid="9" pm="."><plain>The pattern of associations was similar for LF and SDNN </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: These findings suggest that <z:chebi fb="1" ids="25255">MMS</z:chebi> disorders adversely affect cardiac autonomic control and a reduced cardiac autonomic control may contribute to the increased risk of subsequent cardiovascular events in individuals who exhibit <z:chebi fb="1" ids="25255">MMS</z:chebi> disorders </plain></SENT>
</text></document>